Interclean Shanghai

Mylab launches Dry LIA technology in India with MyBox+ diagnostic device

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Mylab Discovery Solutions, a leading biotech firm in India, launched Mybox+ diagnostic device with a range of important tests including thyroid panel (T-3, T-4, TSH), cardiac marker (Troponin), and biomarker (CRP, D-Dimer).

The introduction of MyBox+ and its Dry Luminescence technology represents a transformative step forward in the field of diagnostics. It empowers small labs and clinics, enabling them to offer a broader range of tests and improve patient care. This technology marks a departure from traditional liquid reagent-based testing methods, offering a game-changing solution for small labs and clinics that previously faced limitations in performing certain tests. Until now, many small labs had to rely on outsourcing these tests to larger facilities, which often resulted in delayed results and increased costs associated with sample transportation.

MyBox+ is a portable device powered by optical AI engines, to deliver highly accurate, rapid quantitative and qualitative results in clinical samples. The device can be used to conduct tests for 30+ diseases and can invaluable diagnostic tool that can be easily set up in small labs and centres.

Hasmukh Rawal, MD & co-founder, Mylab said, “The launch of these Dry-LIA Test with MyBox+ represents our commitment to provide healthcare professionals with advanced tools to facilitate early diagnosis and better patient outcomes. These Tests utilize state-of-the-art dry luminescence technology, providing rapid and reliable results within minutes even at small centres. By bringing advanced testing capabilities to small labs, we aim to democratize diagnostic services, ensuring that critical tests are accessible to all, regardless of geographic location or facility size”.

Dry Luminescence Assay testing is a diagnostic technique that utilizes luminescent reactions to detect and quantify specific substances or biomarkers in biological samples. Unlike traditional liquid-based assays, dry luminescence assays are designed to be performed on test strips, without the need for processing.

The detection of thyroid hormones, including triiodothyronine (T3), thyroxine (T4), and thyroid-stimulating hormone (TSH), is essential for accurate diagnosis and effective management of thyroid conditions such as hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid); Detecting Troponin levels is crucial in diagnosing and managing cardiac conditions. CRP is an essential biomarker used to assess inflammation within the body and aids in the diagnosis and management of various conditions, including infections, autoimmune diseases, and cardiovascular diseases. D-Dimer test is a crucial diagnostic tool in evaluating thrombotic disorders; etc.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »